9-35088871-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_032634.4(PIGO):​c.*221G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000225 in 573,816 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00068 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000059 ( 0 hom. )

Consequence

PIGO
NM_032634.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0890

Publications

0 publications found
Variant links:
Genes affected
PIGO (HGNC:23215): (phosphatidylinositol glycan anchor biosynthesis class O) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid which contains three mannose molecules in its core backbone. The GPI-anchor is found on many blood cells and serves to anchor proteins to the cell surface. This protein is involved in the transfer of ethanolaminephosphate (EtNP) to the third mannose in GPI. At least three alternatively spliced transcripts encoding two distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
PIGO Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hyperphosphatasia with intellectual disability syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hyperphosphatasia-intellectual disability syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000684 (104/152104) while in subpopulation AFR AF = 0.00244 (101/41418). AF 95% confidence interval is 0.00205. There are 1 homozygotes in GnomAd4. There are 51 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGONM_032634.4 linkc.*221G>A 3_prime_UTR_variant Exon 11 of 11 ENST00000378617.4 NP_116023.2 Q8TEQ8-1
PIGONM_001201484.2 linkc.*221G>A 3_prime_UTR_variant Exon 13 of 13 NP_001188413.1 Q8TEQ8-2
PIGONM_152850.4 linkc.*221G>A 3_prime_UTR_variant Exon 12 of 12 NP_690577.2 Q8TEQ8-2
PIGOXM_005251619.4 linkc.*221G>A 3_prime_UTR_variant Exon 11 of 11 XP_005251676.1 Q8TEQ8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGOENST00000378617.4 linkc.*221G>A 3_prime_UTR_variant Exon 11 of 11 1 NM_032634.4 ENSP00000367880.3 Q8TEQ8-1

Frequencies

GnomAD3 genomes
AF:
0.000684
AC:
104
AN:
152104
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000593
AC:
25
AN:
421712
Hom.:
0
Cov.:
6
AF XY:
0.0000362
AC XY:
8
AN XY:
220786
show subpopulations
African (AFR)
AF:
0.00168
AC:
20
AN:
11940
American (AMR)
AF:
0.0000643
AC:
1
AN:
15554
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10878
East Asian (EAS)
AF:
0.00
AC:
0
AN:
23958
South Asian (SAS)
AF:
0.00
AC:
0
AN:
38940
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22260
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1622
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
274170
Other (OTH)
AF:
0.000179
AC:
4
AN:
22390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000684
AC:
104
AN:
152104
Hom.:
1
Cov.:
32
AF XY:
0.000686
AC XY:
51
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.00244
AC:
101
AN:
41418
American (AMR)
AF:
0.000197
AC:
3
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000744

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hyperphosphatasia with intellectual disability syndrome 2 Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.9
DANN
Benign
0.43
PhyloP100
-0.089
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1056995769; hg19: chr9-35088868; API